gliclazide has been researched along with Retinal Neovascularization in 1 studies
Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.
Retinal Neovascularization: Formation of new blood vessels originating from the retinal veins and extending along the inner (vitreal) surface of the retina.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to assess the potential beneficial effects of gliclazide and other sulphonylureas on ischemia-induced retinal neovascularization." | 3.74 | Comparisons between the beneficial effects of different sulphonylurea treatments on ischemia-induced retinal neovascularization. ( Kimura, T; Kita, M; Suzuma, K; Takagi, H; Watanabe, D; Yoshimura, N, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kimura, T | 1 |
| Takagi, H | 1 |
| Suzuma, K | 1 |
| Kita, M | 1 |
| Watanabe, D | 1 |
| Yoshimura, N | 1 |
1 other study available for gliclazide and Retinal Neovascularization
| Article | Year |
|---|---|
Comparisons between the beneficial effects of different sulphonylurea treatments on ischemia-induced retinal neovascularization.
Topics: Acetylcysteine; Animals; Blood Glucose; Female; Gliclazide; Glyburide; Ischemia; Mice; Oxidative Str | 2007 |